PRESS RELEASE published on 07/03/2025 at 21:19, 10 months 30 days ago Inside Information / Operations of the issuer (acquisitions, sales...) GenSight Biologics closes EUR 3.9M private placement with issuance of ordinary shares, pre-funded warrants, investor warrants. Funds to repay convertible bonds. Maxim Group, LLC acted as placement agent Private Placement Ordinary Shares GenSight Biologics Maxim Group EUR 3.9M
BRIEF published on 07/01/2025 at 08:59, 11 months 2 days ago GenSight Biologics raises nearly €4 million in private placement Private Placement Investment GenSight Biologics Euronext Shares LUMEVOQ ®
PRESS RELEASE published on 07/01/2025 at 08:54, 11 months 2 days ago Inside Information / Operations of the issuer (acquisitions, sales...) GenSight Biologics successfully completes private placement of nearly EUR 4 million, attracting new international investors. Funds to advance gene therapies for retinal diseases and CNS disorders Private Placement GenSight Biologics Gene Therapies Retinal Diseases CNS Disorders
BRIEF published on 06/26/2025 at 07:35, 11 months 7 days ago GenSight Biologics: Advances in Manufacturing Partnership with Catalent Gene Therapy GenSight Biologics LUMEVOQ® NOHL Catalent
PRESS RELEASE published on 06/26/2025 at 07:30, 11 months 7 days ago Inside Information / Other news releases GenSight Biologics achieves significant milestone with new manufacturing partnership with Catalent, successfully transferring upstream phase of LUMEVOQ® manufacturing process Gene Therapy GenSight Biologics LUMEVOQ Catalent Manufacturing Partnership
BRIEF published on 05/13/2025 at 22:05, 1 year ago GenSight Biologics Shareholders Approve Majority of Board's Resolutions Shareholder Meeting Board Resolutions GenSight Biologics LUMEVOQ® Phase III RECOVER
PRESS RELEASE published on 05/13/2025 at 22:00, 1 year ago Inside Information / Other news releases GenSight Biologics announces approval of all resolutions at Combined General Meeting on May 13, 2025. Company highlights achievements of 2024 and strategic priorities for 2025 Strategic Priorities Approval Combined General Meeting GenSight Biologics Achievements
BRIEF published on 04/23/2025 at 20:35, 1 year 1 month ago GenSight Biologics Announces Annual General Meeting Details Annual General Meeting Shareholders Gene Therapy GenSight Biologics Retinal Diseases
PRESS RELEASE published on 04/23/2025 at 20:30, 1 year 1 month ago Inside Information / Other news releases GenSight Biologics to hold Annual General Meeting on May 13, 2025 at 2:00 pm CEST in Paris, France. Procedures for obtaining preparatory documents outlined Annual General Meeting Preparatory Documents GenSight Biologics Gene Therapies Retinal Diseases
BRIEF published on 04/08/2025 at 07:51, 1 year 1 month ago GenSight Biologics Files its 2024 Universal Registration Document AMF Gene Therapy Registration Document GenSight Biologics Retina
Published on 06/03/2026 at 14:00, 25 minutes ago Datametrex Secures New Nutanix Infrastructure Contracts as Enterprise Data Centre Modernization Accelerates
Published on 06/03/2026 at 14:00, 25 minutes ago Sky Gold Corp Reports On Gold And Multi-Element Results Indicating Large Polymetallic System With Critical Minerals At Evening Star, Nevada
Published on 06/03/2026 at 13:25, 1 hour ago Metallic Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$10 Million
Published on 06/03/2026 at 13:00, 1 hour 25 minutes ago CoTec Holdings Corp. Joint Venture, HyProMag USA, to Commence Preparatory Work for Project Execution Phase at Dallas-Fort Worth Texas Hub
Published on 06/03/2026 at 10:30, 3 hours 55 minutes ago Silver Range Partner Excalibur Metals Intersects a Broad Precious Metals Zone, Open at Depth at the Bellehelen Property
Published on 06/03/2026 at 13:30, 55 minutes ago TCL TECH Unveils 2025 ESG Report: Driving Global Sustainability Transformation with Advanced Technology
Published on 06/03/2026 at 13:23, 1 hour 1 minute ago CEWE: Annual General Meeting approves 17th consecutive dividend increase
Published on 06/03/2026 at 13:18, 1 hour 7 minutes ago EQS-Adhoc: Klöckner & Co SE: Decision to launch a delisting tender offer of Worthington Steel at €11.00 per Klöckner & Co-Share published
Published on 06/03/2026 at 13:10, 1 hour 15 minutes ago SensorUp Closes Growth Financing to Scale its Agentic Operations Platform for Heavy Industry
Published on 06/03/2026 at 12:45, 1 hour 40 minutes ago Hong Kong forges new opportunities with Kazakhstan and Central Asia
Published on 06/03/2026 at 14:17, 7 minutes ago Press Release_Successful completion of tender offer on Carrefour notes_June 2026
Published on 06/03/2026 at 12:41, 1 hour 44 minutes ago Disclosure of Share Capital and Voting Rights as of Mai 31, 2026
Published on 06/03/2026 at 11:29, 2 hours 56 minutes ago 2026.06.03 Notice to holders of the Convertible Bond ISIN FR0013521085
Published on 06/03/2026 at 08:45, 5 hours 40 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 20 hours 22 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
